Lv31
256 积分 2024-05-15 加入
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
32分钟前
已完结
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
15天前
已完结
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions
1个月前
已完结
Claudin 18.2 as a novel therapeutic target
1个月前
已完结
Lysine Acetyltransferases (KATs) in Disguise: Diseases Implications
1个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
2个月前
已完结
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
3个月前
已完结
Role of the CXCR6/CXCL16 axis in autoimmune diseases
3个月前
已完结
The global burden of inflammatory bowel disease: from 2025 to 2045
4个月前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
4个月前
已完结
皖公网安备34019202002308
